[Your Name]
[Your Address]
[City, State, ZIP Code]
[Email Address]
[Phone Number]
[Date]

[Congressperson's Name]
[Congressperson's Address]
[City, State, ZIP Code]

Dear [Congressperson's Name],

I am writing to urge you to advocate for equitable food allergy clinical trials, particularly for those trials that receive government funding, including support from the National Institutes of Health (NIH). It is imperative that such trials include a demographically representative population, ensuring that minorities and other historically underrepresented individuals are actively included in these studies.

Food allergies affect millions of Americans, but minority and underserved communities are disproportionately impacted by health disparities. Despite this, these populations remain underrepresented in clinical trials. The lack of diversity in trials not only limits our understanding of how treatments may work across different populations but also perpetuates inequities in healthcare outcomes. When clinical trials do not reflect the true diversity of the U.S. population, we risk developing treatments that are less effective—or even harmful—for certain demographic groups.

By encouraging that government-funded food allergy clinical trials include a representative demographic sample, we can ensure that new therapies are safe and effective for everyone. This approach will promote better outcomes for minority and underserved communities, while advancing the goal of health equity across the board.

I respectfully request your leadership in pushing for legislation that requires equitable representation in all government-funded food allergy clinical trials. Your support can ensure that the benefits of new therapies are accessible to everyone, regardless of background or ethnicity.

Thank you for your time and consideration. I look forward to hearing your thoughts on this important issue.

Sincerely,
[Your Name]